Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in miceH R Lijnen, M-C Alessi, B Van Hoef, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Recombinant human microplasmin: production and potential therapeutic propertiesN Nagai, E Demarsin, B Van Hoef, et al.European Journal of Biochemistry|August 15, 1993
Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinaseD Collen, B Van Hoef, B Schlott, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002
Matrix metalloproteinase inhibition impairs adipose tissue development in miceH R Lijnen, E Maquoi, L B Hansen, et al.European Journal of Biochemistry|August 3, 1987
Amino-acid sequence of human alpha 2-antiplasminH R Lijnen, W E Holmes, B van Hoef, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivationH R Lijnen, B Van Hoef, I Vanlinthout, et al.The Journal of Biological Chemistry|April 15, 1993
On the mechanism of the activation of human plasminogen by recombinant staphylokinaseD Collen, B Schlott, Y Engelborghs, et al.Blood|January 15, 1992
Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1X K Li, H R Lijnen, L Nelles, et al.Journal of Molecular Biology|July 3, 1999
Guiding a docking mode by phage display: selection of correlated mutations at the staphylokinase-plasmin interfaceL Jespers, H R Lijnen, S Vanwetswinkel, et al.The Journal of Biological Chemistry|June 25, 1991
On the mechanism of fibrin-specific plasminogen activation by staphylokinaseH R Lijnen, B Van Hoef, F De Cock, et al.Pageof 6